"Interleukin-17" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A proinflammatory cytokine produced primarily by T-LYMPHOCYTES or their precursors. Several subtypes of interleukin-17 have been identified, each of which is a product of a unique gene.
| Descriptor ID |
D020381
|
| MeSH Number(s) |
D12.644.276.374.465.517 D12.776.467.374.465.517 D23.529.374.465.517
|
| Concept/Terms |
Interleukin-17F- Interleukin-17F
- Interleukin 17F
- IL-17F
- Cytokine ML-1
- Cytokine ML 1
Interleukin-17C- Interleukin-17C
- Interleukin 17C
- IL-17C
- Cytokine CX2
- CX2, Cytokine
Interleukin-17E- Interleukin-17E
- Interleukin 17E
- Interleukin-25
- Interleukin 25
- IL-17E
- IL 17E
Interleukin-17A- Interleukin-17A
- Interleukin 17A
- Cytotoxic T lymphocyte-Associated Antigen 8
- Cytotoxic T lymphocyte Associated Antigen 8
- IL-17A
- CTLA8
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-17".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-17".
This graph shows the total number of publications written about "Interleukin-17" by people in this website by year, and whether "Interleukin-17" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2007 | 2 | 0 | 2 |
| 2008 | 2 | 1 | 3 |
| 2009 | 6 | 1 | 7 |
| 2010 | 3 | 1 | 4 |
| 2011 | 3 | 3 | 6 |
| 2012 | 2 | 2 | 4 |
| 2013 | 0 | 3 | 3 |
| 2014 | 2 | 1 | 3 |
| 2015 | 4 | 3 | 7 |
| 2016 | 4 | 8 | 12 |
| 2017 | 2 | 9 | 11 |
| 2018 | 3 | 3 | 6 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 1 | 2 |
| 2021 | 3 | 0 | 3 |
| 2022 | 0 | 2 | 2 |
| 2023 | 1 | 1 | 2 |
| 2024 | 1 | 4 | 5 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interleukin-17" by people in Profiles.
-
Autoimmune disease risk gene ANKRD55 promotes TH17 effector function through metabolic modulation. J Exp Med. 2025 Nov 03; 222(11).
-
Pancreatic Epithelial IL17/IL17RA Signaling Drives B7-H4 Expression to Promote Tumorigenesis. Cancer Immunol Res. 2024 Sep 03; 12(9):1170-1183.
-
Successful management of pre-existing psoriatic arthritis through targeting the IL-23/IL-17 axis in cancer patients receiving immune checkpoint inhibitor therapy: a case series. RMD Open. 2024 08 30; 10(3).
-
Blocking IL-17a Signaling Decreases Lung Inflammation and Improves Alveolarization in Experimental Bronchopulmonary Dysplasia. Am J Pathol. 2024 Nov; 194(11):2023-2035.
-
Sex-dependent APOE4 neutrophil-microglia interactions drive cognitive impairment in Alzheimer's disease. Nat Med. 2024 Oct; 30(10):2990-3003.
-
Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone loss. Cell. 2024 Jul 11; 187(14):3690-3711.e19.
-
Downregulation of Mirlet7 miRNA family promotes Tc17 differentiation and emphysema via de-repression of ROR?t. Elife. 2024 May 09; 13.
-
Th17/1 and ex-Th17 cells are detected in patients with polyarticular juvenile arthritis and increase following treatment. Pediatr Rheumatol Online J. 2024 Mar 02; 22(1):32.
-
Gut epithelial Interleukin-17 receptor A signaling can modulate distant tumors growth through microbial regulation. Cancer Cell. 2024 01 08; 42(1):85-100.e6.
-
Gut Inflammation in Axial Spondyloarthritis Patients is Characterized by a Marked Type 17 Skewed Mucosal Innate-like T Cell Signature. Arthritis Rheumatol. 2023 11; 75(11):1969-1982.